Kilitch Drugs (India) News

Kilitch Drugs Holds EGM for Capital Increase & Bonus

Kilitch Drugs (India) Limited conducted an Extra-Ordinary General Meeting on March 13, 2026, to approve authorized capital increase and 1:1 bonus share issue through video conferencing.

Kilitch Drugs EGM on March 13 for Capital Increase

Kilitch Drugs (India) Limited schedules EGM for March 13, 2026 to increase authorized capital from ₹25 crore to ₹40 crore and approve 1:1 bonus share issue.

Kilitch Drugs Reports No Deviation in Rights Issue Fund Utilization for Q2 FY26

Kilitch Drugs (India) Limited's monitoring agency report for the quarter ended September 30, 2025, confirms no deviation in the utilization of Rs. 49.92 crore raised through rights issue. The company utilized Rs. 18.30 crore towards its Greenfield project at Pen, Maharashtra, and Rs. 0.61 crore for general corporate purposes, with remaining funds invested in fixed deposits.

Kilitch Drugs Reports 18% Jump in H1FY26 Profit to ₹10.30 Crore

Kilitch Drugs Limited announced an 18.1% increase in Profit After Tax to ₹10.30 crore for H1FY26, up from ₹8.72 crore in H1FY25, driven by improved operational efficiencies and better product mix. The pharmaceutical company also reported 14.23% growth in total income to ₹101.28 crore and completed a rights issue of ₹49.92 lakh to fund its upcoming Greenfield project at Pen.